In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1210/jc.2008-2309PMID 19470632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural basis for androgen specificity and oestrogen synthesis in human aromatase

  2009cited by this paper
• The discovery and mechanism of action of letrozole

  2007cited by this paper
• A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome

  2007cited by this paper
• Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.

  2006cited by this paper
• Utility of recombinant cytochrome p450 enzymes: a drug metabolism perspective.

  2005cited by this paper
• Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

  2005cited by this paper
• Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.

  2001cited by this paper
• Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.

  1997cited by this paper
• Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study.

  1996cited by this paper
• Bimodal distribution of renal cytochrome P450 3A activity in humans.

  1996cited by this paper
• A three‐dimensional model of aromatase cytochrome P450

  1995cited by this paper
• Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.

  1994cited by this paper
• The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature

  1993cited by this paper
• Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg.

  1991cited by this paper
• Aromatase inhibition by flavonoids.

  1990cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• The determination of enzyme inhibitor constants.

  1953cited by this paper
• The Determination of Enzyme Dissociation Constants

  1934cited by this paper

• Cytochrome P450 in GtoPdb v.2025.3

  2025cites this paper
• Molecular Insights into CYP19A1 Mutations and Their Role in Estrogen Production.

  2025cites this paper
• CYP19A1 mediates severe SARS-CoV-2 disease outcome in males

  2023cites this paper
• CYP19A1 mediated sex hormone metabolism promotes severe SARS-CoV-2 disease outcome in males.

  2021cites this paper
• Cytochrome P450 in GtoPdb v.2021.2

  2021cites this paper
• CYP19A1 rs10046 pharmacogenetics in postmenopausal breast cancer patients treated with aromatase inhibitors: One-year follow-up.

  2020cites this paper
• Thermodynamic Activity-Based Progress Curve Analysis in Enzyme Kinetics.

  2017cites this paper
• Genetic Polymorphisms in Estrogen-Related Genes and the Risk of Breast Cancer among Han Chinese Women

  2015cites this paper
• Understanding Aromatase: A Mechanistic Basis for Drug Interactions and New Inhibitors

  2012cites this paper
• Reduced Methadone Clearance During Aromatase Inhibition

  2012cites this paper
• Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

  2012cites this paper
• A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture

  2011cites this paper
• Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer

  2011cites this paper
• Inhibition of aromatase activity in MCF-7aro human breast cancer cells by the natural androgens testosterone and androstenedione

  2010cites this paper